Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Accounts Payables (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Accounts Payables for 16 consecutive years, with $58.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 19.65% year-over-year to $58.4 million, compared with a TTM value of $58.4 million through Dec 2025, up 19.65%, and an annual FY2025 reading of $58.4 million, up 19.65% over the prior year.
  • Accounts Payables was $58.4 million for Q4 2025 at Orthofix Medical, up from $50.5 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $58.4 million in Q4 2025 and bottomed at $19.4 million in Q3 2021.
  • Average Accounts Payables over 5 years is $40.7 million, with a median of $45.5 million recorded in 2023.
  • The sharpest move saw Accounts Payables skyrocketed 111.45% in 2023, then fell 20.95% in 2025.
  • Year by year, Accounts Payables stood at $26.5 million in 2021, then rose by 4.3% to $27.6 million in 2022, then surged by 111.45% to $58.4 million in 2023, then decreased by 16.37% to $48.8 million in 2024, then increased by 19.65% to $58.4 million in 2025.
  • Business Quant data shows Accounts Payables for OFIX at $58.4 million in Q4 2025, $50.5 million in Q3 2025, and $45.1 million in Q2 2025.